Form EFFECT Kyverna Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 2, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agronomics Limited Announces Net Asset Value as at 30 June 2026
- Teemway Gifts to Showcase Innovative Color-Changing Drinkware at SAAC Expo 2026
- Fastsættelse af kuponrenter - Supplerende Kapital 2032 (DKK) - Tier 2
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
